Nektar Therapeutics Statistics

Total Valuation

BMV:NKTR has a market cap or net worth of MXN 2.03 billion. The enterprise value is 1.38 billion.

Market Cap	2.03B
Enterprise Value	1.38B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	12.41M
Shares Outstanding	n/a
Shares Change (YoY)	+9.53%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.14
PB Ratio	7.23
P/TBV Ratio	7.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.51
EV / Sales	0.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.38

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 13.59.

Current Ratio	3.24
Quick Ratio	3.11
Debt / Equity	13.59
Debt / EBITDA	n/a
Debt / FCF	-1.05
Interest Coverage	-5.07

Financial Efficiency

Return on equity (ROE) is -189.46% and return on invested capital (ROIC) is -31.27%.

Return on Equity (ROE)	-189.46%
Return on Assets (ROA)	-26.80%
Return on Invested Capital (ROIC)	-31.27%
Return on Capital Employed (ROCE)	-75.46%
Revenue Per Employee	29.23M
Profits Per Employee	-44.58M
Employee Count	61
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	-3.11M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-78.48%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	13.24
Average Volume (20 Days)	121

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.44

Income Statement

In the last 12 months, BMV:NKTR had revenue of MXN 1.78 billion and -2.72 billion in losses. Loss per share was -194.50.

Revenue	1.78B
Gross Profit	1.33B
Operating Income	-2.86B
Pretax Income	-2.72B
Net Income	-2.72B
EBITDA	-2.79B
EBIT	-2.86B
Loss Per Share	-194.50

Full Income Statement

Balance Sheet

The company has 4.47 billion in cash and 3.82 billion in debt, giving a net cash position of 694.76 million.

Cash & Cash Equivalents	4.47B
Total Debt	3.82B
Net Cash	694.76M
Net Cash Per Share	n/a
Equity (Book Value)	280.79M
Book Value Per Share	22.63
Working Capital	3.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.62 billion and capital expenditures -26.84 million, giving a free cash flow of -3.64 billion.

Operating Cash Flow	-3.62B
Capital Expenditures	-26.84M
Free Cash Flow	-3.64B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.61%, with operating and profit margins of -160.27% and -152.49%.

Gross Margin	74.61%
Operating Margin	-160.27%
Pretax Margin	-152.66%
Profit Margin	-152.49%
EBITDA Margin	-156.59%
EBIT Margin	-160.27%
FCF Margin	n/a

Dividends & Yields

BMV:NKTR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.53%
Shareholder Yield	n/a
Earnings Yield	-133.97%
FCF Yield	-179.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Jun 9, 2025
Split Type	Reverse
Split Ratio	0.0666666667

Scores

BMV:NKTR has an Altman Z-Score of -20.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.1
Piotroski F-Score	3